Patients’ knowledge and fear of colorectal cancer risk in inflammatory bowel disease

Journal of Digestive Diseases

Volumn 17, Issue 6, 2016, Pages 383-391

  Lopez, Anthony ^a   Collet Fenetrier, Benjamin ^a   Belle, Arthur ^a   Peyrin Biroulet, Laurent ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

colorectal cancer, Crohn disease; fear; inflammatory bowel disease; knowledge; ulcerative colitis

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; FEAR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; ULCERATIVE COLITIS;

EID: 84983591320     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12356     Document Type: Article

References (30)

1. Jess T, Loftus EV Jr, Velayos FS et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 2006; 130: 1039–46.
2. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639–45.
3. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23: 1097–104.
4. Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100: 2724–9.
5. Annese V, Daperno M, Rutter MD et al.; European Crohn's and Colitis Organisation. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982–1018.
6. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005; 100: 1345–53.
7. Carrat F, Seksik P, Bouvier AM et al. Aminosalicylates, thiopurines and the risk of colorectal cancer in inflammatory bowel diseases: a case-control study nested in the CESAME cohort. Gastroenterology 2010; 138 Suppl 1: S–47.
8. Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976–2008). Inflamm Bowel Dis 2012; 18: 2247–51.
9. Moser G, Tillinger W, Sachs G et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 853–8.
10. Levenstein S, Li Z, Almer S et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1822–30.
11. Friedman S, Cheifetz AS, Farraye FA et al. Doctor message can alter patients’ behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis 2012; 18: 1531–9.
12. Schölmerich J, Sedlak P, Hoppe-Seyler P, Gerok W. The information needs and fears of patients with inflammatory bowel disease. Hepatogastroenterology 1987; 34: 182–5.
13. Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med 1991; 53: 701–12.
14. Martin A, Leone L, Castagliuolo I, Di Mario F, Naccarato R. What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol 1992; 24: 477–80.
15. Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011; 60: 930–6.
16. Robinson RJ, Hart AR, Mayberry JF. Cancer surveillance in ulcerative colitis: a survey of patients’ knowledge. Endoscopy 1996; 28: 761–2.
17. Siegel CA, Schwartz LM, Woloshin S et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis 2010; 16: 1658–62.
18. Baars JE, Siegel CA, van't Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis 2010; 42: 777–84.
19. Fletcher RH, Lobb R, Bauer MR et al. Screening patients with a family history of colorectal cancer. J Gen Intern Med 2007; 22: 508–13.
20. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 590–8.
21. Politi P, Bodini P, Mortilla MG et al.; European Collaborative Study Group on Inflammatory Bowel Disease. Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort. J Crohns Colitis 2008; 2: 226–32.
22. Bernard A, Langille M, Hughes S, Rose C, Leddin D, Veldhuyzen van Zanten S. A systematic review of patient inflammatory bowel disease information resources on the World Wide Web. Am J Gastroenterol 2007; 102: 2070–7.
23. van der Marel S, Duijvestein M, Hardwick JC et al. Quality of web-based information on inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 1891–6.
24. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51: 123–8.
25. van Rijn AF, Fockens P, Siersema PD, Oldenburg B. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009; 15: 226–30.
26. Rimola J, Ordás I, Rodriguez S et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17: 1759–68.
27. Van Assche G, Dignass A, Bokemeyer B et al.; European Crohn's and Colitis Organisation. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1–33.
28. Fazio VW, Ziv Y, Church JM et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995; 222: 120–7.
29. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 2929–33.
30. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16: 51–60.